Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia
Status:
Unknown status
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The goal of the present study is to evaluate the effect of D-serine, added to antipsychotic
treatment, on negative and cognitive symptoms in schizophrenia.
The investigators are hypothesizing that D-serine will improve cognitive functioning and
negative symptoms.